133 related articles for article (PubMed ID: 1164465)
21. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
22. Measurement of urinary CEA-like substance. An aid in management of patients with bladder carcinoma.
Wahren B; Edsmyr F; Zimmerman R
Cancer; 1975 Oct; 36(4):1490-5. PubMed ID: 1175143
[TBL] [Abstract][Full Text] [Related]
23. Proceedings: Clinical evaluation of CEA in urine of patients with bladder carcinoma.
Korsten CB; Persijn JP; Renaud J
Br J Cancer; 1974 Aug; 30(2):174-5. PubMed ID: 4419334
[No Abstract] [Full Text] [Related]
24. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
[TBL] [Abstract][Full Text] [Related]
25. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
[No Abstract] [Full Text] [Related]
26. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
[No Abstract] [Full Text] [Related]
28. Carcino-embryonic antigen activity in urine of patients with bladder carcinoma. Clinical evaluation of carcino-embryonic antigen. II.
Korsten CB; Persijn JP; Renaud J; Houtzager-Boelens CA
J Clin Chem Clin Biochem; 1976 Aug; 14(8):389-93. PubMed ID: 965892
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder.
Alsabti EA; Saffo MH
Urol Int; 1979; 34(5):387-92. PubMed ID: 494440
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III.
Persijn JP; Korsten CB; Batterman JJ; Tierie AH; Renaud J
J Clin Chem Clin Biochem; 1976 Aug; 14(8):395-9. PubMed ID: 965893
[TBL] [Abstract][Full Text] [Related]
31. The carcinoembryonic antigen test in urologic cancer.
Guinan PD; McKiel C; Sundar B; Veith R; Dubin A; Ablin RJ
Natl Cancer Inst Monogr; 1978 Dec; (49):225-9. PubMed ID: 748773
[TBL] [Abstract][Full Text] [Related]
32. Urinary carcinoembryonic like antigen levels in patients with urinary tract reconstruction using bowels.
Oshiumi Y; Yagi H; Nishitani H; Nakayama C; Kamoi I; Matsuura K; Momose S
Radioisotopes; 1978 Aug; 27(8):456-9. PubMed ID: 734164
[TBL] [Abstract][Full Text] [Related]
33. Assessment of serial CEA determinations in urine of patients with bladder carcinoma.
Zimmerman R; Wahren B; Edsmyr F
Cancer; 1980 Oct; 46(8):1802-9. PubMed ID: 7427883
[TBL] [Abstract][Full Text] [Related]
34. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
Yang SC
Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic antigen in the urine of patients with urothelial carcinoma.
Hall RR; Laurence DJ; Darcy D; Stevens U; James R; Roberts S; Munro Neville A
Br Med J; 1972 Sep; 3(5827):609-11. PubMed ID: 5071696
[TBL] [Abstract][Full Text] [Related]
36. Bladder cancer detection and surveillance: carcinoembryonic antigen as a monitor of neoplastic transformation.
Boileau M; Swartz D; Schmidt K; Schmidt W
J Surg Oncol; 1987 Jun; 35(2):120-3. PubMed ID: 3586682
[TBL] [Abstract][Full Text] [Related]
37. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
38. [Carcinoembryonic antigen (CEA) in tumor tissue, serum and urine in cases with tumors of the urinary tract. A study by immunohistochemistry and radioimmunoassay].
Kanokogi M
Nihon Hinyokika Gakkai Zasshi; 1984 Oct; 75(10):1558-71. PubMed ID: 6396428
[No Abstract] [Full Text] [Related]
39. Carcinoembryonic antigen in patients with urologic cancers.
Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
[No Abstract] [Full Text] [Related]
40. The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease.
Fleisher M; Grabstald H; Whitmore WF; Pinsky CM; Oettgen HF; Schwartz MK
J Urol; 1977 May; 117(5):635-7. PubMed ID: 558345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
